1. Who’s going to do my operation? Expectations for the next generation of surgeons

   • Barbara Lee Bass

   Presidential Address Pages: 1191 - 1198

2. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

   • Jordan M. Winter
   • John L. Cameron
   • Charles J. Yeo

   2005 SSAT Annual Meeting Pages: 1199 - 1211

3. Pancreatic cancer in the general population: Improvements in survival over the last decade

   • Taylor S. Riall
   • William H. Nealon
   • Jean L. Freeman

   OriginalPaper Pages: 1212 - 1224

4. Exocrine function following the whipple operation as assessed by stool elastase

   • Joe Matsumoto
   • L. William Traverso

   OriginalPaper Pages: 1225 - 1229

5. Pancreatic regeneration in chronic pancreatitis requires activation of the Notch signaling pathway

   • Yun Su
   • Peter Büchler
   • Helmut Friess

   OriginalPaper Pages: 1230 - 1242

6. Hospital readmission after pancreaticoduodenectomy

   • Dawn M. Emick
   • Taylor S. Riall
   • Charles J. Yeo

   OriginalPaper Pages: 1243 - 1253

7. Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma

   • Siong-Seng Liau
   • Stanley W. Ashley
   • Edward E. Whang

   OriginalPaper Pages: 1254 - 1263

8. Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy

   • Wande Pratt
   • Shishir K. Maithel
   • Charles M. Vollmer

   OriginalPaper Pages: 1264 - 1279

9. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial

   • Jordan M. Winter
   • John L. Cameron
   • Charles J. Yeo

   OriginalPaper Pages: 1280 - 1290

10. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo

    • Leo Christopher DeRosier
    • Zhi-Qiang Huang
    • Selwyn M. Vickers

    OriginalPaper Pages: 1291 - 1300

11. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer

    • Simon Law
    • Dora L. W. Kwong
    • John Wong

    OriginalPaper Pages: 1301 - 1311

12. Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up

    • Samir Mehta
    • John Bennett
    • Michael Rhodes

    OriginalPaper Pages: 1312 - 1317